|
Date Submitted:
12/11/07
Hits: 19 Rating:  0/5 based on 0 votes
Hepatitis B Drug a Threat to Those With HIV
Description:
Patients infected with both hepatitis B and HIV should not take the hepatitis-fighting drug Baraclude on its own, new research confirms. The problem is that Baraclude (entecavir) can cause HIV to become resistant to life-extending AIDS medications, according to a study in the June 21 New England Journal of Medicine.
Read the Complete Article Similar content: Hepatitis B Drug Triggers HIV Drug Resistance, in Hepatitis New Hepatitis B Drug Better Than Others, in Hepatitis Experimental Hepatitis C Drug 'Promising', in Hepatitis New Hepatitis C Drug Improves Quality of Life, in Hepatitis Biologic Drug Approved to Prevent Hepatitis B in Liver Recipients, in Hepatitis |
